Compare NBTX & RNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NBTX | RNP |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2018 | N/A |
| Metric | NBTX | RNP |
|---|---|---|
| Price | $51.00 | $20.45 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 68.3K | ★ 78.0K |
| Earning Date | 03-31-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.94% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $58.17 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.64 | $19.27 |
| 52 Week High | $57.14 | $22.99 |
| Indicator | NBTX | RNP |
|---|---|---|
| Relative Strength Index (RSI) | 65.31 | 40.03 |
| Support Level | $19.22 | $19.90 |
| Resistance Level | N/A | $20.55 |
| Average True Range (ATR) | 3.29 | 0.26 |
| MACD | 1.71 | -0.06 |
| Stochastic Oscillator | 77.12 | 1.49 |
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances. The Fund seeks to achieve its objectives through a portfolio of income producing common stock issued by REITs and preferred and other debt securities.